Abstract
Percutaneous image-guided ablation is now an established treatment in the control of hepatocellular carcinoma (HCC). While liver transplantation remains the definitive treatment, a lack of donors worldwide excludes this treatment as a realistic possibility for most sufferers. Surgical resection provides the opportunity for cure; however, stringent patient selection criteria employed to avoid complications often means many patients are not eligible for surgery. Thus percutaneous ablation is often an ideal choice for the minimally invasive treatment of early-stage patients who are ineligible for surgery, which can be curative in itself or be utilised as a bridge to future transplantation. With a number of ablation technologies available in the interventional radiologist’s armamentarium, there are few lesions which cannot be treated percutaneously—it is therefore paramount that referral for image-guided ablation is considered in patients who cannot be treated surgically.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci. 2002;963:13–20.
Belghiti J, Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB (Oxford). 2005;7(1):42–9.
Nagase N, Yuki H, Hamada T, Hirose S, Kawashima R, Inokuchi K. The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer. 1984;54(7):1461–5.
Llovet JM, Fuster J, Buix J. The Barcelona approach; diagnosis, staging and treatment of hepatocellular carcinoma. Liver Transpl. 2004;10:115–20.
Pompili M, Francica G, Ponziani FR, Iezzi R, Avolio AW. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation. World J Gastroenterol. 2013;19(43):7515–30.
Weis S, Franke A, Mössner J, Jakobsen JC, Schoppmeyer K. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. Cochrane Database Syst Rev. 2013;12:CD003046.
Bhatia S, et al. Is antibiotic prophylaxis for percutaneous radiofrequency ablation (RFA) of primary liver tumors necessary? Results from a single-center experience. Cardiovasc Intervent Radiol. 2015;38(4):922–8.
Llovet JM, Vilana R, Brú C, et al. Barcelona ClÃnic Liver Cancer (BCLC) Group Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33(5):1124–9.
Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev. 2007;33(5):437–47.
Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;89(10):1206–22.
Wang T, et al. Microwave ablation of hepatocellular carcinoma as first-line treatment: long term outcomes and prognostic factors in 221 patients. Sci Rep. 2016;6:32728.
Brace C. Microwave ablation technology: What every user should know. Curr Probl Diagn Radiol. 2009;38(2):61–7.
Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005;25(Suppl 1):S69–83.
Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee FT Jr. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology. 2005;236(1):132–9.
Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperth. 2016;32(3):339–44.
Wang C, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology. 2015;61(5):1579–90.
Rong G, et al. Long-term outcomes of percutaneous cryoablation for patients with hepatocellular carcinoma within Milan criteria. PLoS One. 2015;10(4):e0123065.
Wu S, Hou J, Ding Y, Wu F, Hu Y, Jiang Q, Mao P, Yang Y. Cryoablation versus radiofrequency ablation for hepatic malignancies. Medicine (Baltimore). 2015;94(49):e2252.
Chakravorty E, et al. Anaesthetic management of radiofrequency tumour ablation: or experience. Indian J Anaesth. 2006;50:123–7.
Wang Y, Luo Q, Li Y, Deng S, Wei S, Li X. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials. PLoS One. 2014;9(1):e84484.
Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107(4):569–77.
Xu Y, et al. Microwave ablation for the treatment of hepatocellular carcinoma that met up-to-seven criteria: feasibility, local efficacy and long-term outcomes. Eur Radiol. 2017;27(9):3877–87.
Liang P, et al. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology. 2005;235(1):299–307.
Xu Y, et al. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma. Chin J Cancer. 2017;36(1):14.
Chinnaratha MA, Chuang MY, Fraser RJ, Woodman RJ, Wigg AJ. Percutaneous thermal ablation for primary hepatocellular carcinoma: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31(2):294–301.
Sutter O, et al. Safety and efficacy of irreversible electroporation for the treatment of hepatocellular carcinoma not amenable to thermal ablation techniques: a retrospective single-center case series. Radiology. 2017;284(3):877–86.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wong, JJ., Kibriya, N. (2019). The Role of Interventional Radiology and Image-Guided Ablation in Primary Liver Cancer. In: Cross, T., Palmer, D. (eds) Liver Cancers. Springer, Cham. https://doi.org/10.1007/978-3-319-92216-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-92216-4_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92215-7
Online ISBN: 978-3-319-92216-4
eBook Packages: MedicineMedicine (R0)